Prescription Drug Rehab Cost: Class-by-Class Treatment and 2026 Pricing
Prescription drug rehab costs $15,000 to $50,000 for a 30-day inpatient program without insurance, or $6,000 to $20,000 out-of-pocket with PPO insurance. Duration varies by drug class: opioid painkillers need 5–7 day detox, benzodiazepines need 10–14+ days of tapering, stimulants like Adderall need 3–7 day stabilization, and sedatives like barbiturates need 10–14+ days. MAT is FDA-approved for prescription opioid use disorder only.
| Drug Class | Detox Duration | 30-Day Inpatient (Self-Pay) | 30-Day (PPO OOP) | MAT Available |
|---|---|---|---|---|
| Opioid painkillers | 5–7 days | $18,000 – $55,000 | $7,500 – $22,000 | Yes |
| Benzodiazepines (Xanax, Valium, Klonopin) | 10–14+ days | $16,000 – $52,000 | $7,000 – $22,000 | No |
| Prescription stimulants (Adderall, Ritalin) | 3–7 days | $14,000 – $45,000 | $5,500 – $18,000 | No (off-label ADAPT-2) |
| Barbiturates/sedatives | 10–14 days | $15,000 – $48,000 | $6,500 – $20,000 | No |
| Z-drugs (Ambien, Lunesta) | 10–14 days | $15,000 – $48,000 | $6,500 – $20,000 | No |
SAMHSA estimates 8.7 million Americans misused prescription drugs in 2023. Treatment costs and protocols vary dramatically by drug class — a single “prescription drug rehab” category masks substantial clinical differences. This guide answers the four most-searched cost questions with a class-by-class breakdown and covers the 2022–2026 developments (Adderall shortage, telehealth prescribing changes, tianeptine emergence) that most prescription drug cost pages skip.
How Long Is Rehab for Prescription Drugs?
Duration varies substantially by drug class.
Prescription Opioid Painkillers (OxyContin, Percocet, Vicodin)
| Phase | Duration |
|---|---|
| Medical detox | 5–7 days |
| Inpatient residential | 30–90 days |
| PHP step-down | 4–6 weeks |
| IOP | 8–12 weeks |
| MAT maintenance | 12–24+ months (often indefinite) |
Same treatment pathway as heroin and fentanyl. MAT (buprenorphine, methadone, Vivitrol) is standard of care. See opioid rehab cost for full detail.
Benzodiazepines (Xanax, Valium, Klonopin)
| Phase | Duration |
|---|---|
| Medical detox (inpatient taper) | 10–14+ days |
| Inpatient residential | 30–60 days |
| PHP | 4–6 weeks |
| IOP | 8–12 weeks |
| Outpatient taper (Ashton Manual) | 4–18 months |
| SSRI + CBT maintenance | 12+ months |
Longest inpatient taper of any prescription drug. See benzo rehab cost.
Prescription Stimulants (Adderall, Ritalin, Vyvanse, Concerta)
| Phase | Duration |
|---|---|
| Stabilization | 3–7 days |
| Inpatient residential | 30 days (severe cases only) |
| IOP | 12 weeks |
| Standard outpatient | Ongoing |
No FDA-approved MAT. Off-label protocols (Vivitrol + bupropion per ADAPT-2) are sometimes used. See meth rehab cost for related stimulant treatment detail.
Barbiturates and Z-Drugs (Ambien, Lunesta, Sonata)
Clinically treated like benzodiazepines — gradual taper with long-acting substitute, 10–14+ day inpatient detox, same post-acute management.
Minimum Recommended Treatment
NIDA recommends minimum 90 days of total structured treatment across all prescription drug classes. The sequence — inpatient + PHP + IOP + outpatient — spreads those 90 days across 4–5 months of decreasing intensity.
How Much Is 28 Days of Prescription Drug Rehab?
Standard insurance billing cycle. Cost depends on drug class.
| Drug Class | Self-Pay 28 Days | PPO OOP 28 Days |
|---|---|---|
| Opioid painkillers (MAT included) | $16,500 – $51,000 | $7,000 – $20,500 |
| Benzodiazepines (intensive detox) | $15,000 – $48,000 | $6,500 – $20,500 |
| Prescription stimulants | $13,000 – $42,000 | $5,000 – $16,500 |
| Barbiturates/Z-drugs | $14,000 – $45,000 | $6,000 – $18,500 |
Worked example (opioid painkiller rehab): Facility bills $35,000 for 28 days. Plan: $2,000 deductible / 20% coinsurance / $8,700 OOP max.
- Deductible: $2,000
- 20% of $33,000: $6,600
- Running total: $8,600 — below OOP max → $8,600
Insured patients typically hit OOP max during the stay and pay $0 for remaining inpatient and any step-down treatment in the same plan year. See how much does rehab cost.
Do You Have to Pay for Prescription Drug Rehab?
Rarely at full price. Payment sources:
| Source | Typical Out-of-Pocket |
|---|---|
| PPO insurance | $7,000 – $9,500 annual OOP max |
| HMO | $5,000 – $17,000 |
| Medicaid | $0 – $100 |
| Medicare | Varies (Part A inpatient, Part D medications) |
| EAP | Short-term |
| VA | No cost for eligible veterans |
| Self-pay with financing | Sliding scale, scholarships, single-case agreements |
See does insurance cover rehab for full payment framework.
Class-by-Class Treatment Detail
Prescription Opioid Painkillers
The clinical pathway for OxyContin, Percocet, Vicodin, hydrocodone, oxycodone, and tramadol is identical to heroin or fentanyl treatment: medical detox, MAT initiation (buprenorphine most common), residential or IOP, long-term MAT.
MAT medications:
- Buprenorphine generic: $100–$300/month (self-pay); $10–$75 (insured)
- Suboxone brand: $400–$600/month; $25–$150 insured
- Sublocade (monthly injection): $1,600–$1,800; $50–$300 insured
- Brixadi (weekly injection): $600–$1,800; $50–$350 insured
- Methadone (OTP): $300–$500; $50–$200 insured
- Vivitrol: $1,200–$1,500; $50–$250 insured
Treatment duration: Minimum 12–24 months of MAT per NIDA; often indefinite. See opioid rehab cost for full detail.
Benzodiazepines
No FDA-approved MAT. Treatment centers on gradual tapering — the most expensive and longest detox of any substance because abrupt cessation can cause fatal seizures. Extended Ashton Manual outpatient tapers run 4–18 months.
What doctors prescribe for benzo withdrawal:
- Long-acting benzo substitute (diazepam) for the taper itself
- Anticonvulsants (phenobarbital, gabapentin, pregabalin)
- Non-benzo anxiolytics (SSRIs, buspirone, hydroxyzine)
- Sleep aids (trazodone, mirtazapine, low-dose doxepin)
See benzo rehab cost for full protocol detail.
Prescription Stimulants
No FDA-approved MAT. Treatment is primarily behavioral (CBT, contingency management). Off-label pharmacotherapy based on the 2021 ADAPT-2 NEJM trial (Vivitrol + bupropion) is sometimes used.
Key recency issue: The 2022–2024 Adderall supply shortage drove many patients with legitimate ADHD prescriptions to seek illicit sources or develop misuse patterns with alternative stimulants. Prescription stimulant use disorder has risen substantially over this period.
Barbiturates and Z-Drugs
Barbiturates (phenobarbital, secobarbital) and Z-drugs (zolpidem/Ambien, eszopiclone/Lunesta, zaleplon/Sonata) share cross-tolerance with benzodiazepines and are treated with identical taper-based protocols. Inpatient detox runs 10–14+ days with gradual substitution and reduction.
Emerging Prescription/Pseudo-Prescription Concerns (2024–2026)
Tianeptine (“ZaZa”, “Tianaa”, “Neptune’s Fix”)
An antidepressant approved in other countries but not the U.S. Sold in gas stations and convenience stores in some states. Has opioid-like effects at high doses. Dependence develops rapidly. Withdrawal resembles opioid withdrawal. Several states (Alabama, Georgia, Florida, Indiana, Michigan, Minnesota, Ohio, Tennessee) have scheduled it as a controlled substance. Treatment: taper under medical supervision; MAT with buprenorphine is sometimes used because of opioid-receptor activity.
Kratom
Botanical substance with opioid-like effects at high doses. Sold in supplement stores. Dependence develops with regular use; withdrawal resembles opioid withdrawal. Treatment: taper; buprenorphine is sometimes used. Kratom use disorder is not a formal DSM-5 diagnosis but is clinically treated like opioid use disorder.
Gabapentin Misuse
Gabapentin alone is minimally euphoric but amplifies opioid effects. Rising misuse pattern combined with opioids has led to scheduling in some states (Kentucky, Virginia). Detox is unnecessary for gabapentin alone; treatment focuses on polysubstance management.
Telehealth Prescribing Post-Pandemic
Pandemic-era telehealth rules that expanded controlled-substance prescribing (including stimulants and buprenorphine) have tightened since 2023 but remain evolving as of 2026. Current rules allow continued telehealth MAT with buprenorphine; stimulant prescribing rules remain under review.
Why Prescription Drug Addiction Differs From Street Drugs
Prescription drug use disorder often begins with legitimate prescriptions. The trajectory:
- Legitimate prescription for pain, anxiety, ADHD, or sleep
- Tolerance development — same dose becomes less effective
- Dose escalation (provider-directed or patient-initiated)
- Physical dependence — withdrawal when doses are missed
- Use disorder — continued use despite consequences
This is not moral failure but predictable physiological response to long-term use of dependence-producing medications. Current prescribing guidelines now recommend:
- Opioid painkillers: shortest effective course
- Benzodiazepines: 2–4 weeks maximum for most indications
- Stimulants: continued assessment of ADHD response and monitoring for misuse
Patients who developed use disorder on older, less-restrictive prescribing patterns often feel shame that shouldn’t be attached to a predictable iatrogenic phenomenon.
The Cost of Untreated Prescription Drug Use
Varies by drug class but consistently expensive:
| Category | Annual Range |
|---|---|
| Illicit purchases (when prescriptions run out) | $5,000 – $50,000+ |
| Lost wages | $10,000 – $40,000 |
| Healthcare (related conditions) | $3,000 – $30,000 |
| Legal costs (diversion, DUI) | $5,000 – $25,000 |
| Conservative annual total | $23,000 – $145,000+ |
Insurance-capped first-year treatment at $7,000–$9,500 OOP is almost always less.
Does Insurance Cover Prescription Drug Rehab?
Yes — ACA + MHPAEA + 2024 final rule. Every drug class is covered. See does insurance cover rehab.
Carrier pages: Aetna · Cigna · UnitedHealthcare · BCBS · Humana · Kaiser · Molina
Pre-Admission Questions
- Does the facility have a protocol for my specific drug class (opioid, benzo, stimulant)?
- If benzo: is extended-length-of-stay authorization available for safe tapering?
- If opioid: is MAT available (bup, methadone, Vivitrol) at admission?
- If stimulant: is contingency management or off-label ADAPT-2 protocol offered?
- Is dual diagnosis treatment available for the original prescribed-for condition (chronic pain, anxiety, ADHD)?
- What’s my OOP max, and what’s met year-to-date?
Program Length
| Duration | Best For | Insured OOP | Self-Pay |
|---|---|---|---|
| 30 days | Standard length, most prescription drug classes | $6,000 – $20,000 | $15,000 – $50,000 |
| 60 days | Severe cases, benzo tapering, complex psychiatric comorbidity | Capped at OOP max | $30,000 – $100,000 |
| 90+ days | High-dose long-duration use, multiple prior treatments | Capped at OOP max | $45,000 – $150,000 |
If You Don’t Have Insurance
See rehab cost without insurance.
Sources
- Substance Abuse and Mental Health Services Administration. “National Survey on Drug Use and Health.” 2024. https://www.samhsa.gov/data/
- National Institute on Drug Abuse. “Prescription Drugs and Cold Medicines DrugFacts.” 2024. https://nida.nih.gov/publications/drugfacts/prescription-drugs
- Centers for Disease Control and Prevention. “Prescription Drug Monitoring.” 2024. https://www.cdc.gov/drugoverdose/pdmp/
- Drug Enforcement Administration. “National Drug Threat Assessment.” 2024. https://www.dea.gov/resources/reports
- American Psychiatric Association. “Practice Guideline for the Treatment of Patients with Substance Use Disorders.” 2024.
- Trivedi MH, et al. “Bupropion and Naltrexone in Methamphetamine Use Disorder (ADAPT-2).” New England Journal of Medicine. 2021.
- American Society of Addiction Medicine. “National Practice Guideline for the Treatment of Opioid Use Disorder.” 2020.
- U.S. Department of Labor. “Mental Health Parity and Addiction Equity Act Final Rule (September 2024).” https://www.dol.gov/agencies/ebsa/laws-and-regulations/laws/mental-health-and-substance-use-disorder-parity
Your Plan May Not Cover Prescription Drug Treatment.
Even with insurance, many people discover their plan doesn't cover residential treatment at the level they need. A broker who specializes in behavioral health coverage can review your situation and find a plan that works.
Call 1-866-454-9577Free Consultation · No Obligation
Prodest Insurance Group is a licensed, independent health insurance brokerage. Calling the number above connects you with a licensed insurance agent, not a treatment facility. Insurance placement is a separate service from treatment referral.
Frequently Asked Questions
How long is rehab for prescription drugs?
Duration depends heavily on the drug class. Prescription opioid painkillers (OxyContin, Percocet, Vicodin): 5–7 day detox + 30–90 day treatment + 12–24+ months MAT. Benzodiazepines (Xanax, Valium, Klonopin): 10–14+ day inpatient taper + 30–90 day treatment + 4–18 month outpatient taper continuation. Prescription stimulants (Adderall, Ritalin, Vyvanse): 3–7 day stabilization + 30–90 day treatment. Barbiturates and Z-drugs (Ambien, Lunesta): 10–14+ day taper + 30–90 day treatment. NIDA recommends minimum 90 days of total structured treatment for all prescription drug use disorders. Most patients sequence 30-day inpatient → PHP → IOP → long-term outpatient.
How much is 28 days of prescription drug rehab?
A 28-day inpatient prescription drug rehab stay — the standard insurance billing cycle — costs $14,000 to $47,000 without insurance and $5,500 to $18,500 out-of-pocket with PPO insurance. Cost varies by drug class: benzodiazepine stays are most expensive ($15,000–$48,000) because the 10–14 day detox portion requires intensive monitoring. Opioid painkiller stays run in the mid-range because MAT costs apply. Prescription stimulant stays are less expensive ($13,000–$42,000) because detox is simpler. Insured patients typically hit their 2026 out-of-pocket maximum of $7,000–$9,500 within the first 10–14 days.
Do you have to pay for prescription drug rehabilitation?
Rarely at full sticker price. Under ACA and MHPAEA, insurance must cover prescription drug use disorder treatment as an essential health benefit. PPO plans pay 60–80% after deductible, capped at the $7,000–$9,500 annual out-of-pocket maximum. Medicaid plans cover at $0–$100 copay. Uninsured patients can access sliding-scale fees, scholarship funds, single-case agreements, medical loans, and payment plans. The 2024 MHPAEA final rule strengthened parity enforcement, specifically reducing prior-authorization barriers for MAT medications like buprenorphine for prescription opioid use disorder.
Does insurance cover prescription drug rehab?
Yes. Under ACA and MHPAEA, every marketplace plan and most employer plans cover prescription drug use disorder treatment as an essential health benefit regardless of drug class — opioid painkillers, benzodiazepines, prescription stimulants, sedatives. Coverage includes medical detox, residential inpatient, PHP, IOP, outpatient, MAT (for opioid painkiller use disorder), and behavioral therapies. PPO plans pay 60–80% after deductible. Medicaid covers at $0–$100 copay. Coverage for off-label treatment (e.g., bupropion + Vivitrol for prescription stimulant use disorder) varies by plan.
How much does prescription drug rehab cost without insurance?
Without insurance, a 30-day inpatient prescription drug rehab program costs $15,000 to $50,000. Medical detox adds $1,500 to $12,000 depending on drug class: opioid painkiller detox $2,000–$8,000 (5–7 days), benzodiazepine detox $3,500–$12,000+ (10–14+ days, most expensive), prescription stimulant stabilization $1,200–$5,500 (3–10 days), barbiturate/sedative detox $3,500–$10,000 (10–14 days). Ongoing MAT for prescription opioid use disorder adds $100–$1,800 monthly depending on medication.
Is MAT available for prescription drug addiction?
MAT is FDA-approved for prescription opioid use disorder (OxyContin, Percocet, Vicodin, hydrocodone, oxycodone, tramadol). The same three medications used for heroin and fentanyl — buprenorphine (Suboxone, Sublocade, Brixadi), methadone, naltrexone (Vivitrol) — work for prescription opioids. For other prescription drug classes, there are no FDA-approved MAT medications: benzodiazepines are treated with tapering and non-addictive anxiolytics (SSRIs, buspirone, hydroxyzine, gabapentin); prescription stimulants are treated behaviorally (CBT, contingency management) with occasional off-label use of Vivitrol + bupropion based on the 2021 ADAPT-2 trial for meth; barbiturates and sedatives are treated with tapering and supportive care.
Is prescription drug addiction increasing?
Mixed trends. Prescription opioid misuse has declined since 2015 due to stricter prescribing rules, but prescription stimulant misuse has risen — particularly during and after the 2022–2024 Adderall shortage, which drove many patients to seek alternative sources. Benzodiazepine misuse remains persistent at 4.8 million Americans (SAMHSA). Emerging concerns include tianeptine (sold as 'ZaZa' or 'Tianaa' — an antidepressant in other countries with opioid-like effects), gabapentin misuse (particularly with opioids), and kratom. Telehealth prescribing rule changes post-pandemic continue to evolve and affect access to controlled substances.
Why is prescription drug addiction increasing for stimulants specifically?
Prescription stimulant misuse (Adderall, Vyvanse, Ritalin, Concerta) has risen notably since 2022 due to several factors. The 2022–2024 Adderall supply shortage forced many patients with legitimate ADHD prescriptions to seek alternatives, sometimes from illicit sources. Pandemic-era telehealth prescribing expanded access to stimulants, and some providers prescribed more liberally before regulatory tightening in 2023–2024. Adolescent and young-adult misuse for academic performance has grown. Unlike opioids, there's no FDA-approved MAT for stimulant use disorder — treatment relies on CBT, contingency management, and off-label protocols.